CD8A and neoplasm: Concomitant with a significant anti-tumor response at day 21 post-initiation of bintrafusp alfa treatment, there was an increased CD4+ (Figure 2E) and CD8+ (Figure 2F) T-cell presence per milligram tumor in bintrafusp alfa compared to control treated animals.